Is BPC-157 a GLP-3? The Triple Agonist Mechanism Explained
Understanding how BPC-157's receptor targets produce its therapeutic effects.
BPC-157's Drug Class: What It Means
BPC-157 is a 15-amino acid peptide fragment derived from a body protection compound found in human gastric juice. Its proposed mechanisms include upregulating growth hormone receptors in tendon fibroblasts, promoting angiogenesis (new blood vessel formation), modulating nitric oxide signaling, and reducing inflammatory cytokines. Animal studies suggest it accelerates healing of tendons, ligaments, muscles, and gut mucosa.
Frequently Asked Questions
What drug class is BPC-157?
BPC-157 is a Peptide Fragment (Gastric Protein Derivative). BPC-157 is a 15-amino acid peptide fragment derived from a body protection compound found in human gastric juice. Its proposed mechanisms include upregulating growth hormone receptors in tendon fibroblasts, promoting angiogenesis (new blood vessel formation), modulating nitric oxide signaling, and reducing inflammatory cytokines. Animal studies suggest it accelerates healing of tendons, ligaments, muscles, and gut mucosa.
How does BPC-157 work for weight loss?
BPC-157 causes weight loss through its receptor activity. BPC-157 is a 15-amino acid peptide fragment derived from a body protection compound found in human gastric juice. Its proposed mechanisms include upregulating growth hormone receptors in tendon fibroblasts, promoting angiogenesis (new blood vessel formation), modulating nitric oxide signaling, and reducing inflammatory cytokines. Animal studies suggest it accelerates healing of tendons, ligaments, muscles, and gut mucosa.
Exploring Retatrutide Access?
See how patients are accessing retatrutide through physician-supervised telehealth and compounding pharmacies.
Not FDA approved. Access requires physician oversight.
Affiliate links — we may earn a commission at no cost to you.